Detalhe da pesquisa
1.
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK).
Br J Haematol
; 192(6): 1031-1034, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32805081